An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens

American Journal of Tropical Medicine and Hygiene

Volumn 89, Issue 5, 2013, Pages 973-982

  Goodyear, Andrew ^a   Strange, Linda ^a   Rholl, Drew A ^b   Silisouk, Joy ^c   Dance, David A B ^c   Schweizer, Herbert P ^a   Dow, Steven ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b NORTH PARK UNIVERSITY   (United States)

^c MAHOSOT HOSPITAL   (Laos)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; NORFLOXACIN; POLYMYXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; BACTERIUM ISOLATION; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; MALE; MOUSE; NONHUMAN;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BURKHOLDERIA PSEUDOMALLEI; CULTURE MEDIA; FECES; FEMALE; HUMANS; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED ICR; NORFLOXACIN; POLYMYXIN B; SENSITIVITY AND SPECIFICITY;

EID: 84888589870     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0119     Document Type: Article

References (63)

1. Limmathurotsakul D, Peacock SJ, 2011. Melioidosis: a clinical overview. Br Med Bull 99: 125-139.
2. Currie BJ, Dance DAB, Cheng AC, 2008. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 102: S1-S4.
3. Currie BJ, Ward L, Cheng AC, 2010. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 Year Darwin Prospective Study. PLoS Negl Trop Dis 4: e900.
4. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G, 2005. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 43: 970-972.
5. Chaowagul W, Simpson AJ, Suputtamongkol Y, White NJ, 1999. Empirical cephalosporin treatment of melioidosis. Clin Infect Dis 28: 1328.
6. Loveleena, Chaudhry R, Dhawan B, 2004. Melioidosis; the remarkable imitator: recent perspectives. J Assoc Physicians India 52: 417-420.
7. Poe RH, Vassallo CL, Domm BM, 1971. Meliodosis: the remarkable imitator. Am Rev Respir Dis 104: 427-431.
8. Ashdown LR, 1979. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology (Phila) 11: 293-297.
9. Glass MB, Beesley CA, Wilkins PP, Hoffmaster AR, 2009. Comparison of four selective media for the isolation of Burkholderia mallei and Burkholderia pseudomallei. Am J Trop Med Hyg 80: 1023-1028.
10. Peacock SJ, Chieng G, Cheng AC, Dance DAB, Amornchai P, Wongsuvan G, Teerawattanasook N, Chierakul W, Day NPJ, Wuthiekanun V, 2005. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 43: 5359-5361.
11. Thomas AD, 1977. The isolation of Pseudomonas pseudomallei from soil in north Queensland. Aust Vet J 53: 408.
12. Smith MD, Wuthiekanun V, Walsh AL, White NJ, 1995. Quantitative recovery of Burkholderia pseudomallei from soil in Thailand. Trans R Soc Trop Med Hyg 89: 488-490.
13. Miller WR, Pannell L, Cravitz L, Tanner WA, Ingalls MS, 1948. Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei: I. morphology, cultivation, viability, and isolation from contaminated specimens. J Bacteriol 55: 115-126.
14. Farkas-Himsley H, 1968. Selection and rapid identification of Pseudomonas pseudomallei from other gram-negative bacteria. Am J Clin Pathol 49: 850-856.
15. Brundage WG, Thuss CJJ, Walden DC, 1968. Four fatal cases of melioidosis in U. S. soldiers in Vietnam. Bacteriologic and pathologic characteristics. Am J Trop Med Hyg 17: 183-191.
16. So SY, Chau PY, Leung YK, Lam WK, Yu DY, 1983. Successful treatment of melioidosis caused by a multiresistant strain in an immunocompromised host with third generation cephalosporins. Am Rev Respir Dis 127: 650-654.
17. Wuthiekanun V, Smith MD, Dance DAB, White NJ, 1995. Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand. Trans R Soc Trop Med Hyg 89: 41-43.
18. Trunck LA, Propst KL, Wuthiekanun V, Tuanyok A, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Peacock SJ, Keim P, Dow SW, Schweizer HP, 2009. Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis 3: e519.
19. Moore RA, DeShazer D, Reckseidler S,Weissman A,Woods DE, 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43: 465-470.
20. Chan YY, Tan TM, Ong YM, Chua KL, 2004. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob Agents Chemother 48: 1128-1135.
21. Mima T, Schweizer HP, 2010. The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother 54: 3113-3120.
22. Viktorov DV, Zakharova IB, Podshivalova MV, Kalinkina EV, Merinova OA, Ageeva NP, Antonov VA, Merinova LK, Alekseev VV, 2008. High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 102 (Suppl 1): S103-S110.
23. Keith KE, Oyston PC, Crossett B, Fairweather NF, Titball RW, Walsh TR, Brown KA, 2005. Functional characterization of OXA-57, a class D β-Lactamase from Burkholderia pseudomallei. Antimicrob Agents Chemother 49: 1639-1641.
24. Rholl DA, Papp-Wallace KM, Tomaras AP, Vasil ML, Bonomo RA, Schweizer HP, 2011. Molecular investigations of PenAmediated β-lactam resistance in Burkholderia pseudomallei. Front Microbiol 2: 139.
25. Livermore DM, Chau PY, Wong AI, Leung YK, 1987. β-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance. J Antimicrob Chemother 20: 313-321.
26. Holden MTG, Titball RW, Peacock SJ, Cerdeno-Tarraga AM, Atkins T, Crossman LC, Pitt T, Churcher C,Mungall K, Bentley SD, Sebaihia M, Thomson NR, Bason N, Beacham IR, Brooks K, Brown KA, Brown NF, Challis GL, Cherevach I, Chillingworth T, Cronin A, Crossett B, Davis P, DeShazer D, Feltwell T, Fraser A, Hance Z, Hauser H, Holroyd S, Jagels K, Keith KE, Maddison M, Moule S, Price C, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Simmonds M, Songsivilai S, Stevens K, Tumapa S, Vesaratchavest M, Whitehead S, Yeats C, Barrell BG, Oyston PCF, Parkhill J, 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 101: 14240-14245.
27. Burtnick MN,Woods DE, 1999. Isolation of polymyxin b-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin b resistance. Antimicrob Agents Chemother 43: 2648-2656.
28. Wuthiekanun V,DanceDA, Wattanagoon Y, Supputtamongkol Y, Chaowagul W, White NJ, 1990. The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol 33: 121-126.
29. Dannenberg AMJ, Scott EM, 1958. Melioidosis: pathogenesis and immunity in mice and hamsters. II. Studies with avirulent strains of Malleomyces pseudomallei. Am J Pathol 34: 1099-1121.
30. Eickhoff TC, Bennett JV, Hayes PS, Feeley J, 1970. Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents. J Infect Dis 121: 95-102.
31. Dance DA, Wuthiekanun V, Chaowagul W, White NJ, 1989. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 24: 295-309.
32. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD, 2004. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderiamallei to 35 antimicrobial agents. J Antimicrob Chemother 54: 1134-1138.
33. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Mace K, Chou CJ, 2008. Gut microbiotamodulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22: 2416-2426.
34. DeShazer D, Brett PJ, Carlyon R, Woods DE, 1997. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol 179: 2116-2125.
35. Goodyear A, Bielefeldt-Ohmann H, Schweizer H, Dow S, 2012. Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One 7: e37324.
36. Hwang JM, Piccinini TE, Lammel CJ, Hadley WK, Brooks GF, 1986. Effect of storage temperature and pH on the stability of antimicrobial agents in MIC trays. J Clin Microbiol 23: 959-961.
37. Ivashkiv E, 1973. Ampicillin. Florey K, Brewer GA, eds. Analytical Profiles Drug Substances. New York: Academic Press, 1-61.
38. Al-Izzi SA, Al-Bassam LS, 1989. In vitro susceptibility of Pseudomonas mallei to antimicrobial agents. Comp Immunol Microbiol Infect Dis 12: 5-8.
39. Nye KJ, Fallon D, Frodsham D, Gee B, Graham C, Howe S, Messer S, Turner T, Warren RE, 2002. An evaluation of the performance of XLD, DCA, MLCB, and ABC agars as direct plating media for the isolation of Salmonella enterica from faeces. J Clin Pathol 55: 286-288.
40. Bauer AW, Kirby WM, Sherris JC, Turck M, 1966. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45: 493-496.
41. Wikler MA, Cockerill FR, Bush K, Dudley MN, Eliopoulos GM, Hardy DJ, Hecht DW, Hindler JF, Patel JB, Powell M, Turnidge JD, Weinstein MP, Zimmer BL, Ferraro MJ, Swenson JM, 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard. Clin Lab Standards Institute 29: 1-53.
42. Liss LR, 1987. New M 13 host:DH5αF' competent cells. Focus 9: 13.
43. Romero CD, Chopin SF, Buck G, Martinez E, Garcia M, Bixby L, 2005. Antibacterial properties of common herbal remedies of the Southwest. J Ethnopharmacol 99: 253-257.
44. Currie BJ,MayoM, Anstey NM, Donohoe P, Haase A, Kemp DJ, 2001. A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 65: 177-179.
45. Inglis TJJ, Garrow SC, Adams C, Henderson M, Mayo M, 1998. Dry-season outbreak of melioidosis in Western Australia. Lancet 352: 1600.
46. Cottew GS, Sutherland AK, Meehan JF, 1952. Melioidosis in sheep in Queensland. Description of an outbreak. Aust Vet J 28: 113-123.
47. Ralph A, McBride J, Currie BJ, 2004. Transmission of Burkholderia pseudomallei via breastmilk in Northern Australia. Pediatr Infect Dis J 23: 1169-1171.
48. Stanton AT, Fletcher W, 1925. Melioidosis, a disease of rodents communicable to man. Lancet 205: 10-13.
49. Heng BH, Goh KT, Yap EH, Loh H, Yeo M, 1998. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore 27: 478-484.
50. Puthucheary SD, Lin HP, Yap PK, 1981. Acute septicaemic melioidosis: a report of seven cases. Trop Geogr Med 33: 19-22.
51. Paton JPT, Peck CR, Van De Schaaf A, 1947. Report on a case of melioidosis from Siam. BMJ 1: 336-337.
52. Currie BJ, Fisher DA, Howard DM, Burrow JNC, Selvanayagam S, Snelling PL, Anstey NM, Mayo MJ, 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74: 121-127.
53. Jayanetra P, Pipatanagul S, Punyagupta S, Ratanabanangkoon K, Varavithya W, 1974. Pseudomonas pseudomallei: 1. Infection in Thailand. Southeast Asian J Trop Med Public Health 5: 487-491.
54. West TE, Myers ND, Limmathurotsakul D, Liggitt HD, Chantratita N, Peacock SJ, Skerrett SJ, 2010. Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am J Trop Med Hyg 83: 1066-1069.
55. Howard K, Inglis TJ, 2003. Novel selective medium for isolation of Burkholderia pseudomallei. J Clin Microbiol 41: 3312-3316.
56. Galimand M, Dodin A, 1982. Focus on melioidosis throughout the world. Bull Soc Pathol Exot 75: 375-383.
57. Brook MD, Currie B, Desmarchelier PM, 1997. Isolation and identification of Burkholderia pseudomallei from soil using selective culture techniques and the polymerase chain reaction. J Appl Microbiol 82: 589-596.
58. Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS,MayoM,Wuthiekanun V, Brettin TS, Nierman WC, Peacock SJ, Currie BJ, Wagner DM, Keim P, 2008. Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics 9: 566.
59. Harkins DM, DeShazer D, Woods DE, Brinkac LM, Brown KA, Hung GC, Tuanyok A, Zhang B, Nierman WC, 2009. Burkholderia pseudomallei 1106b Chromosome I, Whole Genome Shotgun Sequence. Available at: http://www.ncbi.nlm.nih.gov/ nuccore/CM000774.1. Accessed December 16, 2010.
60. Glass MB, Steigerwalt AG, Jordan JG, Wilkins PP, Gee JE, 2006. Burkholderia oklahomensis sp.Nov., a Burkholderia pseudomallei-like species formerly known as the Oklahoma Strain of Pseudomonas pseudomallei. Int J Syst Evol Microbiol 56: 2171-2176.
61. Zhao N, Qu C, Wang E, Chen W, 1995. Phylogenetic evidence for the transfer of Pseudomonas cocovenenans (van Damme et al. 1960) to the genus Burkholderia as Burkholderia cocovenenans (van Damme et al. 1960) comb. Nov. Int J Syst Bacteriol 45: 600-603.
62. Coenye T, LiPuma JJ, Henry D, Hoste B, Vandemeulebroecke K, Gillis M, Speert DP, Vandamme P, 2001. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol 51: 271-279.
63. Marshall K, Shakya S, Greenhill AR, Padill G, Baker A, Warner JM, 2010. Antibiosis of Burkholderia ubonensis againist Burkholderia pseudomallei, the causative agent for melioidosis. Southeast Asian J Trop Med Public Health 41: 904-912.